FIELD: medicine.
SUBSTANCE: invention refers to biotechnology, and can be used for producing lipopolysaccharide (LPS). S. flexneri strain No. 1605-8, serotype 2a is recovered from a patient suffering severe shigellosis Flexner and deposited in Federal State Institution L.A. Tarasevich State Institution of Standardisation and Control, No. 285. The strain is effective in preparing vaccine and diagnostic products.
EFFECT: produced LPS exhibits high specificity and does not react with diagnostic monovalent serums to antibodies of other serotypes.
1 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
STRAIN OF BACTERIUM SHIGELLA SONNEI, PHASE 1, STABLE PRODUCER OF S-LIPOPOLYSACCHARIDE | 2001 |
|
RU2241031C2 |
METHOD FOR PRODUCING A COMPLEX SHIGELLOSIS DRUG | 2015 |
|
RU2614123C1 |
SYNTHETIC INVAPLEX | 2007 |
|
RU2440136C2 |
NEWLY RECOVERED BORDETELLA PERTUSSIS BACTERIA STRAIN - PERTUSSIS TOXIN PRODUCER | 2009 |
|
RU2407788C1 |
HAEMOPHILUS INFLUENZAE B N 326 BACTERIAL STRAIN, STABLE PRODUCER OF CAPSULAR SACCHARIDE | 2011 |
|
RU2465316C1 |
METHOD FOR SEPARATION OF LIPOPOLYSACCHARIDES OF GRAM-NEGATIVE BACTERIA | 2010 |
|
RU2478712C2 |
SHIGELLA SONNEI BACTERIAL STRAIN USEABLE FOR PREPARING VITAL VACCINE AGAINST SONNE DYSENTERY | 0 |
|
SU1708351A1 |
IpaD-PROTEIN SHIGELLA AND APPLYING IT AS SHIGELLA INFECTIONS VACCINE | 2007 |
|
RU2450826C2 |
BACTERIOPHAGE Escherichia coli V32 STRAIN FOR IDENTIFICATION OF Escherichia coli BACTERIA SEROGROUP O157 | 2010 |
|
RU2425877C1 |
CRYPTOGAMIC PREPARATION - PROBIOTIC OF COMBINED EFFECT | 2008 |
|
RU2388813C1 |
Authors
Dates
2011-04-10—Published
2009-10-21—Filed